A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Access Catheters
Phase of Trial: Phase III
Latest Information Update: 25 Jan 2016
At a glance
- Drugs Tenecteplase (Primary)
- Indications Catheter thrombosis
- Focus Therapeutic Use
- Acronyms TROPICS-2
- Sponsors Genentech
- 25 Jan 2016 Last checked against ClinicalTrials.gov
- 29 Mar 2011 Primary endpoint identified as treatment success as reported by ClinicalTrials.gov.
- 24 Dec 2009 New trial record.